Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 28, 2013

View Archived Issues

Activity of AXL/c-Met inhibitor CEP-40783 described in vitro and in vivo

Bayer Schering Pharma synthesizes new Mnk1 inhibitors for cancer

Cubist completes acquisition of Optimer Pharmaceuticals

Amgen reports active third quarter 2013

Merck Serono and Selvita enter oncology collaboration targeting metabolic pathways

Merck & Co. plans BLA submission for multivalent HPV vaccine

Intranasal formulation of teriparatide may improve compliance

Shire announces reorganization progress of third quarter 2013

Potent, small-molecule, pyridopyrimidinone inhibitor of schwannoma tumorigenesis described

Development and characterization of a first-in-class bacterial inhibitor

Clinical trials show efficacy of netupitant/palonosetron combination

FDA committee supports approval of simeprevir as part of combination therapy for hepatitis C

FDA approves GE Healthcare's brain imaging drug for Alzheimer's disease and dementia

Five Prime provides update on two antibody candidates entering phase I trials

Pfizer discloses new DGAT2 inhibitors

Novel stem cell microparticles claimed by ReNeuron

New chimeric/humanized antibodies bind to human tau protein

Tissue Therapies files application to conduct pivotal VitroGro ECM trial

NovelMed Therapeutics divulges new monoclonal antibodies

Novel nucleic acid vectors presented by Columbia University

ViiV Healthcare files single-tablet regimen MAA for people living with HIV

Imugene executes sale and purchase agreement to acquire Biolife Science

Zohydro ER approved by the FDA for pain

EMA committee recommends approval of Lundbeck's Brintellix

CHMP issues opinion on compassionate use of Gilead's sofosbuvir for chronic HCV infection

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...